Kymera Therapeutics, Inc.
NASDAQ:KYMRBiotechnology
Healthcare
$119.39 +1.67%
+$1.50 today
- Market cap
- $10.19B
- Beta
- 2.03
- P/E (TTM)
- -28.3
- EPS (TTM)
- -$3.23
52W Low $36.65High $103.00
Volume 0.72M
Average 0.58M
Price history
Kymera Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+84.19%
Period high
$138.86
Period low
$64.27
Latest
$119.39
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Oct 29, 2026 | Oct 29, 2026 | |
| 10-Q | Oct 29, 2026 | Oct 29, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 1, 2026 | Oct 1, 2026 | |
| SC 13G/A | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 3 | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 27, 2026 | Jul 27, 2026 | |
| 8-K | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 7, 2026 | Jul 7, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 |
Competitors
Who does Kymera Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about KYMR's filings, answered from its disclosures.
What is the latest KYMR filing?
The latest filing shown is 8-K dated Oct 29, 2026.
How many recent filings does KYMR have?
Intrinsic Alpha currently shows 20 recent filings for KYMR.
Continue the stock analysis
Jump to another research area for this company.